All stories tagged :

Sample Category Title

Sample Category Description. ( Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. )

Aline Wellness Clinic Recognized as Premier Mobile Med Spa Service in...

admin

Tháng 10 29

Pr Newswire

ZKH Group Limited Announces US$50 Million Share Repurchase Program

admin

1 năm ago

Pr Newswire

NaaS Technology Inc. Announces Completion of ADS Ratio Change

admin

1 năm ago

People

Australia E-commerce Market Databook 2024: Opportunities, Shares, Consumer Attitude & Behaviour...

admin

1 năm ago

People

Germany E-commerce Market Report 2024-2028: Major Verticals, Market Share by Key...

admin

1 năm ago

People

Skin Health Foods Market Report 2024: Analysis by Indication, Region and...

admin

1 năm ago

Pr Newswire

Opus Genetics Announces $1.7 Million in Project-based Funding from the Foundation...

admin

1 năm ago

Pr Newswire

Umoja Biopharma Announces Publication in Blood Highlighting Successful Generation of In...

admin

1 năm ago

Pr Newswire

Provectus Biopharmaceuticals Announces Investor Webinar for 2024 Annual Meeting of Stockholders

admin

1 năm ago

Pr Newswire

Araris Biotech AG Appoints Dr. Ulf Grawunder to Scientific Advisory Board

admin

1 năm ago

Pr Newswire

Conduit Pharmaceuticals to Join Russell 3000® Index

admin

1 năm ago

1 2 3 … 1.087 1.088 1.089 1.090 1.091 1.092 1.093 … 1.107 1.108 1.109 Page 1.090 of 1.109

Featured

Pr Newswire

IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The...

admin

6 giờ ago

Pr Newswire

Glucose Health, Inc. Appoints Strategic Investor Christopher J. Jemapete to Its...

admin

6 giờ ago

Pr Newswire

Sofwave to Participate in Upcoming November Investor Conferences

admin

6 giờ ago

Pr Newswire

Belite Bio to Participate in the Deutsche Bank ADR Virtual Investor...

admin

6 giờ ago

admin

6 giờ ago

IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The...

NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, today announced that The Ohio State University has been added as a new clinical site in the ongoing Phase 1...